Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Treace Medical Concepts, Inc. (TMCI) had Revenue of $209.36M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$209.36M
Net Income	$-55.74M
Cost of Goods Sold	$41.09M
Gross Profit	$168.26M
Operating Expenses	$265.05M
Operating Income	$-55.69M
Non-Operating Income/Expense	$-0.06M
Pre-Tax Income	$-55.74M
Normalized Pre-Tax Income	$-55.74M
Income after Taxes	$-55.74M
Income from Continuous Operations	$-55.74M
Consolidated Net Income/Loss	$-55.74M
Normalized Income after Taxes	$-55.74M
EBIT	$-55.69M
EBITDA	$-48.12M
Weighted-Average Shares Outstanding (Basic)	62.11M
Weighted-Average Shares Outstanding (Diluted)	62.11M
Earnings per Share (EPS) (Basic)	$-0.90
Earnings per Share (EPS) (Diluted)	$-0.90
Balance Sheet Financials
Current Assets	$161.40M
Property, Plant, and Equipment	$25.95M
Long-Term Assets	$55.69M
Total Assets	$217.09M
Current Liabilities	$34.92M
Long-Term Debt	$53.31M
Long-Term Liabilities	$69.28M
Total Liabilities	$104.20M
Common Equity	$112.89M
Tangible Shareholders Equity	$92.00M
Shareholders Equity	$112.89M
Common Shares Outstanding	62.36M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-37.17M
Cash Flow from Investing Activities	$35.38M
Cash Flow from Financial Activities	$0.16M
Beginning Cash	$12.98M
End Cash	$11.35M
Increase/Decrease in Cash	$-1.63M
Stock-Based Compensation	$30.60M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.62
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.32
Debt to Equity Ratio	0.47
Gross Margin	80.37%
Operating Margin	-26.60%
EBIT Margin	-26.60%
EBITDA Margin	-22.98%
Pre-Tax Profit Margin	-26.63%
Profit Margin	-26.63%
Free Cash Flow	$-48.76M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.96
Inventory Turnover	1.05
Receiveable Turnover	5.13
Days Sales in Receivables	71.14
Return on Equity	-49.38%
Return on Tangible Equity	-60.59%
Return on Assets	-25.68%
Return on Investments	-33.54%
Book Value Per Share	$1.81
Free Cash Flow per Share	$-0.79
Operating Cash Flow per Share	$-0.60

Data from Zacks Investment Research, Inc.